| 000 | 01621 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515121942.0 | ||
| 264 | 0 | _c20081021 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1522-8517 | ||
| 024 | 7 |
_a10.1215/15228517-2008-019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJakacki, Regina I | |
| 245 | 0 | 0 |
_aA phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. _h[electronic resource] |
| 260 |
_bNeuro-oncology _cAug 2008 |
||
| 300 |
_a569-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLomustine _xadministration & dosage |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aTemozolomide |
| 700 | 1 | _aYates, Allan | |
| 700 | 1 | _aBlaney, Susan M | |
| 700 | 1 | _aZhou, Tianni | |
| 700 | 1 | _aTimmerman, Robert | |
| 700 | 1 | _aIngle, Ashish M | |
| 700 | 1 | _aFlom, Lynda | |
| 700 | 1 | _aPrados, Michael D | |
| 700 | 1 | _aAdamson, Peter C | |
| 700 | 1 | _aPollack, Ian F | |
| 773 | 0 |
_tNeuro-oncology _gvol. 10 _gno. 4 _gp. 569-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1215/15228517-2008-019 _zAvailable from publisher's website |
| 999 |
_c17991198 _d17991198 |
||